INNOGEN-B (02591) fell more than 7% in afternoon trading, hitting a record low of HK$12.33. At the time of writing, the stock was down 6.16% at HK$12.49, with a turnover of HK$11.02 million. The company's annual results showed revenue of RMB 132 million and a net loss of RMB 341 million, representing a 95.41% year-on-year increase in losses. Research and development expenses doubled during the period to RMB 206 million. Notably, the lock-up period for INNOGEN-B's cornerstone investors is set to expire on May 14, 2026, with the related shares becoming tradable on May 15. The cornerstone investors collectively hold 4.201 million shares.